Novel therapy slows tumor growth in 85% of advanced breast cancer patients: Study

[News]

A novel therapy designed to attack tumors in patients with a genetic mutation in either BRCA1 or BRCA2, slowed tumor growth in 85 percent of advanced breast cancer patients treated in a small study, researchers report in the July 6 issue of The Lancet.

More... (http://www.news-medical.net/news/20100706/Novel-therapy-slows-tumor-growth-in-8525-of-advanced-breast-cancer-patients-Study.aspx)